RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM A PHASE 1/2 STUDY

被引:0
|
作者
Wang, Raymond [1 ]
Ficicioglu, Can [2 ]
Giugliani, Roberto [3 ]
Nevoret, Marie-Laure [4 ]
Fiscella, Michele [4 ]
Yang, Lin [4 ]
Cho, Yoonjin [4 ]
Phillips, Dawn [4 ]
Falabella, Paulo [4 ]
机构
[1] Univ Calif Irvine, CHOC Childrens Hosp, Dept Pediat, Div Metab Disorders, Orange, CA 92668 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Univ Fed Rio Grande do Sul, HCPA, Med Genet Serv, Dept Genet, Porto Alegre, RS, Brazil
[4] REGENXBIO, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
92
引用
收藏
页码:305 / 305
页数:1
相关论文
共 50 条
  • [21] First in-human intracisternal dosing of RGX-111 (adeno-associated virus 9/human α-L-iduronidase) for a 20-month-old child with mucopolysaccharidosis type I (MPS I): 1 year follow-up
    Wang, Raymond Y.
    Beydoun, Tammam
    Movsesyan, Nina
    Kan, Shih-Hsin
    Taylor, Mery
    Stockton, Winnie
    Nestrasil, Igor
    Pukenas, Bryan
    Falabella, Paulo
    Cho, Yoonjin
    Nevoret, Marie-Laure
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S110 - S110
  • [22] Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I-Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
    Bernardo, Maria Ester M.
    Tucci, Francesca
    Consiglieri, Giulia
    Oficialdegui, Maria Luz Uria
    Fumagalli, Francesca
    De Pellegrin, Maurizio
    Cossutta, Matilde
    Filisetti, Chiara
    Manitto, Maria Pia
    Butera, Carla
    Dane, Giulia
    Camesasca, Chiara
    Parini, Rossella
    Riera, Mireia Del Toro
    de Heredia, Cristina Diaz
    Aiuti, Alessandro
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02) : 10 - 11
  • [23] Autologous Ex-Vivo Lentiviral Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results from an Ongoing Phase 1/2 Study
    Kohn, Donald B.
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandez, Augustine
    Kuo, Caroline Y.
    De Oliveira, Satiro N.
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan
    Booth, Claire
    MOLECULAR THERAPY, 2023, 31 (04) : 727 - 728
  • [24] Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease
    Kanter, Julie
    Walters, Mark C.
    Hsieh, Matthew M.
    Krishnamurti, Lakshmanan
    Kwiatkowski, Janet
    Kamble, Rammurti T.
    von Kalle, Christof
    Kuypers, Frans A.
    Cavazzana, Marina
    Leboulch, Philippe
    Joseney-Antoine, Marcelyne
    Asmal, Mohammed
    Thompson, Alexis A.
    Tisdale, John F.
    BLOOD, 2016, 128 (22)
  • [25] Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease
    Kanter, Julie
    Walters, Mark C.
    Hsieh, Matthew
    Krishnamurti, Lakshmanan
    Kwiatkowski, Janet L.
    Kamble, Rammurti
    von Kalle, Christof
    Joseney-Antoine, Marcelyne
    Pierciey, Francis J., Jr.
    Shi, Weiliang
    Asmal, Mohammed
    Thompson, Alexis A.
    Tisdale, John F.
    BLOOD, 2017, 130
  • [26] Treatment with pentosan polysulphate in patients with mucopolysaccharidosis type I: Results from an open label, randomized, monocentric phase 2 study
    Hennermann, Julia B.
    Goekce, Seyfullah
    Solyom, Alexander
    Mengel, Eugen
    Schuchman, Edward H.
    Simonaro, Calogera M.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S56 - S56
  • [27] Validation of a GMP stem cell gene therapy manufacturing process for mucopolysaccharidosis type II (MPS II) in preparation for an approved phase I/II clinical trial
    Ellison, Stuart M.
    Buckland, Karen
    Ishikawalearmonth, Yuko
    Booth, Claire
    Wynn, Robert
    Jones, Simon
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 39 - 39
  • [28] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Kohn, D. B.
    Sevilla, J.
    Rao, G.
    Chitty Lopez, M.
    Almarza, E.
    Terrazas, D.
    Zubicaray, J.
    Gonzalez-Vicent, M.
    Chetty, K.
    O'Toole, G.
    Xu-Bayford, J.
    Nicoletti, E.
    Fernandes, A.
    Kuo, C.
    de Oliveira, S.
    Moore, T. B.
    Choi, G.
    Zeini, M.
    Mesa-Nunez, C.
    Thrasher, A. J.
    Bueren, J.
    Schwartz, J.
    Booth, C.
    MOLECULAR THERAPY, 2022, 30 (04) : 550 - 550
  • [29] LENTIVIRAL-MEDIATED EX-VIVO GENE THERAPY FOR PEDIATRIC PATIENTS WITH SEVERE LEUKOCYTE ADHESION DEFICIENCY-I (LAD-I): INTERIM RESULTS FROM AN ONGOING PHASE 1/2 STUDY
    Kohn, Donald
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    Booth, Claire
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 61 - 62
  • [30] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Booth, Claire
    Sevilla, Julian
    Rao, Gayatri R.
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    de Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Kohn, Donald B.
    BLOOD, 2022, 140 : 7774 - 7775